Last reviewed · How we verify
Placebo drug of DW-1030 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo drug of DW-1030 (Placebo drug of DW-1030) — Daewon Pharmaceutical Co., Ltd.. Placebo drugs do not have an active pharmacological mechanism; they are used as controls in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo drug of DW-1030 TARGET | Placebo drug of DW-1030 | Daewon Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo drug of DW-1030 CI watch — RSS
- Placebo drug of DW-1030 CI watch — Atom
- Placebo drug of DW-1030 CI watch — JSON
- Placebo drug of DW-1030 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo drug of DW-1030 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-drug-of-dw-1030. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab